1. Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
   Qingyuan Cheng et al, 2022, Journal of Ovarian Research CrossRef
2. Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
   Mina Sharbatoghli et al, 2022, Frontiers in Genetics CrossRef
3. Heat Shock Proteins and HSF1 in Cancer
   Anna M. Cyran et al, 2022, Frontiers in Oncology CrossRef
4. A study on the biological function of heat shock factor 1 proteins in breast cancer
   Xiaolan Wang et al, 2018, Oncology Letters CrossRef
5. Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
   Abdullah Hoter et al, 2019, Cancers CrossRef
6. Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy
   Rhiane Moody et al, 2021, Cancers CrossRef
7. HSF1 as a Cancer Biomarker and Therapeutic Target
   Richard L. Carpenter et al, 2019, Current Cancer Drug Targets CrossRef
8. Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
   Hwang-Yeol Lee et al, 2021, Scientific Reports CrossRef
9. Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer
   Amy L. Wilson et al, 2018, Cancer Epidemiology, Biomarkers & Prevention CrossRef
10. HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
    A. Elisa Pasqua et al, 2023, Journal of Medicinal Chemistry CrossRef
11. A study on the biological function of heat shock factor 1 proteins in breast cancer
    Xiaolan Wang et al, 2018, Oncology Letters CrossRef